ISRTP

2009 Endocrine Workshop
The Endocrine Disruptor Screening Program:
What Can Screening Results Tell Us About Potential Adverse Endocrine Effects?

September 9-10, 2009
Lister Hill Center Auditorium
(NIH Building 38A)
National Institutes of Health
Bethesda, MD

TWO-DAY PROGRAM  

DAY 1 - SEPTEMBER 9, 2009

8:00 - 9:00

Registration and Continental Breakfast

9:00 - 9:30

Welcome and Workshop Overview
Terry F. Quill
, Quill Law Group LLC (Workshop Chair) SLIDES AUDIO


SESSION I
Strengths and Weaknesses of the EDSP Screening Assays
 

9:30 - 9:45 Session Introduction
Angelina Duggan
, Exponent (Moderator) SLIDES AUDIO
9:45 - 10:05 EDSP Battery and Status
Gary Timm
, EPA SLIDES AUDIO
10:05 - 12:15

 

Panel Presentations and Discussion

  • Shelley Tyl, RTI
    Challenges in Conducting and Interpreting Tier 1 EDSP Screening Assays: CRO Perspective SLIDES AUDIO

10:25 - 10:45 BREAK
10:45 - 12:15
  • Sue Marty, Dow Chemical Corp.
    Mammalian Tier 1 EDSP Screening Assays: What Do they Tell Us? SLIDES AUDIO
     

  • Pat Guiney, SC Johnson
    Wildlife Tier 1 EDSP Screening Assays: What Do They Tell Us? SLIDES AUDIO
     

  • Christopher Borgert, Applied Pharmacology and Toxicology Inc.
    Staging Screening and Testing
    SLIDES AUDIO

  SESSION 1 PANEL DISCUSSION AUDIO
12:15 - 1:00

LUNCH

1:00 - 1:40

KEYNOTE
Overview of the Endocrine System and its Relevance to EDSP Screening
Ray Witorsch
, Medical College of Virginia SLIDES & AUDIO  AUDIO ONLY


SESSION II
Incorporating Existing Data into the EDSP
1:40 - 1:55

Session Introduction
Erik R. Janus
, CropLife America (Moderator) SLIDES AUDIO

1:55 - 2:15

What Current Information Fulfills the Needs of EDSP Screening?
Steven L. Levine
, Monsanto SLIDES AUDIO

2:15 - 2:35 What Can EDSP Screening Tell Us That the FIFRA Test Guidelines Cannot?
James T. Stevens
, Wake Forest University School of Medicine SLIDES AUDIO
2:35 - 2:55

BREAK

2:55 - 4:10

Panel Presentations and Discussion

4:10 - 4:55

KEYNOTE
Can the EDSP Identify “Endocrine Disruptors?
Gio Gori
, The Health Policy Center AUDIO

5:00 - 7:00

RECEPTION
Exhibitor Sponsored
Lister Hill Foyer


DAY 2 - SEPTEMBER 10, 2009
8:00 - 9:00   Registration and Continental Breakfast
9:00 - 9:15 Day Two Introduction AUDIO
Terry Quill
, Quill Law Group LLC

SESSION
III
Point - Counterpoint
Assessing Cumulative Effects of Endocrine Active Substances
9:15 - 9:30

Session Introduction
Rick Becker
, American Chemistry Council (Moderator) SLIDES AUDIO

9:30 - 10:00

Techniques For Assessing Endocrine Cumulative Risk
Robert Golden
, ToxLogic LLC SLIDES AUDIO

10:00 - 10:30 Limitations of EDSP Data For Assessing Cumulative Risk
Christopher Borgert
, Applied Pharmacology and Toxicology Inc. SLIDES AUDIO
10:30 - 11:45 Panel Presentations and Discussion
  • Tim Pastoor, Syngenta SLIDES AUDIO
     

  • Jane Ellen Simons, EPA

  SESSION 3 PANEL DISCUSSION AUDIO
11:45 - 12:30

LUNCH


SESSION
IV
Beyond EDSP Tier 1 Screening – Endocrine Testing in the 21st Century

12;30 - 12:45

Session Introduction
Gary Burin
, Technology Sciences Group Inc. (Moderator) SLIDES

12:45 - 1:05

Correlation of Genomic Methods With In Vivo Studies
George Daston
, Proctor & Gamble SLIDES  AUDIO

1.05 - 1:25

21st Century Screening Assessment of Pesticides – An Agency View
Vicki Dellarco
, EPA SLIDES AUDIO

1:25 - 1:40 What Can ToxCast Tell Us About Endocrine Disruption?
Keith Houck
, EPA Center for Computational Toxicology SLIDES AUDIO
1:40 - 1:55 Ethical Considerations and Alternative Testing Methods
Troy Seidle
, The Humane Society SLIDES AUDIO
2:10 - 2:40 SESSION 4 PANEL DISCUSSION AUDIO
2:40 - 3:00

BREAK


SESSION V
EDSP Implementation – Legal and Regulatory Considerations
3:00 - 3:15

Session Introduction
Mike White
, Chemical Producers & Distributors Association (Moderator) AUDIO

3:15 - 3:35 EPA’s Implementation of EDSP Screening
Bill Jordan
, EPA SLIDES AUDIO
3:35 - 3:55 Legal and Regulatory Issues Related to EDSP Implementation
Terry Quill
, Quill Law Group LLC SLIDES AUDIO
3:55- 5:00

Panel Presentations and Discussion

  • Scott Slaughter, Center for Regulatory Effectiveness
    Information Quality Concerns
    AUDIO
     

  • Doug Nelson, CropLife America
    Implementation Concerns for the Pesticide Industry
    SLIDES AUDIO
     

  • Glenn Simon, Rhodia Inc.
    Forming EDSP Screening Consortia SLIDES AUDIO

  SESSION 5 PANEL DISCUSSION AUDIO
5:00 ADJOURN

 

 BACK TO THE TOP